# FDA 483 - AltaSciences Clinical Los Angeles Inc. - March 24, 2017

Source: https://www.globalkeysolutions.net/records/483/altasciences-clinical-los-angeles-inc/6591ff29-733e-4e5f-b1fe-5d33ad1f6b14

> FDA 483 for AltaSciences Clinical Los Angeles Inc. on March 24, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: AltaSciences Clinical Los Angeles Inc.
- Inspection Date: 2017-03-24
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: WCCT Global, LLC, a Contract Research Organization in Cypress, CA, was cited for significant deviations in clinical investigation conduct. An inspection revealed that an unlisted and untrained physician performed critical end-of-study assessments and signed investigator's signature blocks for multiple subjects. This indicates a failure to adhere to the investigational plan and proper delegation of authority.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/yvonne-lacour-davis/cf2434a3-26fc-4506-9476-ffe1af0db513)

Company: https://www.globalkeysolutions.net/companies/altasciences-clinical-los-angeles-inc/977107a9-0682-40d1-b775-8c0cb8c7e822

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6